JUser: :_load: Unable to load user with ID: 37389

Immunotherapy in Genitourinary Cancers: T-cell Activation and Check Point Therapies - Sumit Subudhi

Sumit Subudhi presents exciting data on immunotherapy and check point inhibitors in genitourinary cancer.  Dr. Subudhi’s discussion includes data on patient overall survival in renal cell carcinoma and a case study showing a remarkable example of a patient being treated with ipilimumab and resulting in a durable and curative response. 


Sumit K. Subudhi, MD, PhD
Assistant Professor, Department of Genitourinary 
Medical Oncology, Division of Cancer Medicine,
The University of Texas MD Anderson Caner Center, Houston, Texas